Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Highly Accessed Editorial

Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?

Mike JL Peters12 and Michael T Nurmohamed123*

Author affiliations

1 Department of Internal Medicine, VU University Medical Centre, PO Box 7057, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands

2 Department of Rheumatology, VU University Medical Centre, PO Box 7057, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands

3 Jan van Breemen Research Institute | Reade, Dr Jan van Breemenstraat 2, 1056 AB Amsterdam, the Netherlands

For all author emails, please log on.

Citation and License

Arthritis Research & Therapy 2013, 15:111  doi:10.1186/ar4185


See related research by Desai et al., http://arthritis-research.com/content/14/6/R270

Published: 19 March 2013

Abstract

Rheumatoid arthritis (RA) is associated with a similar cardiovascular risk to that in diabetes, and therefore cardiovascular risk management (CV-RM) - that is, identification and treatment of cardiovascular risk factors (CRFs) - is mandatory. However, whether and to what extent this is done in daily clinical practice is unknown. In a retrospective cohort investigation, CV-RM was therefore compared between rheumatologists and primary care physicians (PCPs). Remarkably, CRFs in RA were less frequently identified and managed by rheumatologists in comparison with PCPs. In addition, PCPs assessed CRFs less frequently in RA than in diabetes. Obviously, there is a clear need for improvement of CV-RM in RA and this should be a joint effort from the rheumatologist and the PCP.